SEC Form 4 · Updated Daily
NBIX
— NEUROCRINE BIOSCIENCES, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| ROBERTS BRYAN E | Director | 4,044,789 | 2009-12-22 | — |
| VENROCK HEALTHCARE CAPITAL PARTNERS LP | 10%+ Owner | 4,044,789 | 2009-12-22 | — |
| VHCP Management, LLC | 10%+ Owner | 4,044,789 | 2009-12-22 | — |
| VHCP Co-Investment Holdings, LLC | 10%+ Owner | 4,044,789 | 2009-12-22 | — |
| Hove Anders D | 10%+ Owner | 4,044,789 | 2009-12-22 | — |
| BVF PARTNERS L P/IL | 10%+ Owner | 3,527,700 | 2011-10-12 | P |
| BIOTECHNOLOGY VALUE FUND L P | 10%+ Owner | 3,527,700 | 2011-10-12 | P |
| BIOTECHNOLOGY VALUE FUND II LP | Reporting Owner | 3,527,700 | 2011-10-12 | P |
| BVF INC/IL | 10%+ Owner | 3,527,700 | 2011-10-12 | P |
| LAMPERT MARK N | 10%+ Owner | 3,527,700 | 2011-10-12 | P |
| BVF INVESTMENTS LLC | Reporting Owner | 3,527,700 | 2011-10-12 | P |
| GORMAN KEVIN CHARLES | Director | 525,636 | 2026-09-11 | A |
| HAWRAN PAUL W | Director | 244,883 | 2006-05-17 | S |
| VALE WYLIE W | Director | 231,872 | 2006-03-03 | S |
| Bozigian Haig P. | Officer | 157,651 | 2021-02-08 | S |
| Gano Kyle | Director · Officer | 157,266 | 2026-09-11 | A |
| COUGHLIN TIMOTHY | Director | 137,961 | 2017-02-06 | S |
| LYONS GARY A | Director | 122,141 | 2026-05-21 | M |
| VALEUR JENSEN MARGARET E | Officer | 118,256 | 2011-02-28 | S |
| Grigoriadis Dimitri E. | Officer | 87,273 | 2021-10-07 | M |
| BENEVICH ERIC | Officer | 70,683 | 2026-09-11 | A |
| Lippoldt Darin | Officer | 59,212 | 2026-09-11 | A |
| MOLLICA JOSEPH A | Director | 57,354 | 2017-04-12 | M |
| OBrien Christopher Flint | Officer | 55,946 | 2018-02-06 | F |
| ROBERTS EIRY | Officer | 51,331 | 2026-09-28 | — |
| ABERNETHY MATT | Officer | 47,828 | 2026-09-11 | A |
| RASTETTER WILLIAM H | Director | 43,678 | 2026-05-21 | M |
| LYLE CORINNE H | Director | 43,283 | 2018-05-07 | S |
| Lloyd-Smith Malcolm | Officer | 42,337 | 2023-02-08 | S |
| POPS RICHARD F | Director · Officer | 37,798 | 2026-05-21 | M |
| Cooke Julie | Officer | 25,961 | 2026-09-11 | A |
| Onyia Jude | Officer | 24,583 | 2026-09-11 | A |
| Delaet Ingrid | Officer | 20,708 | 2026-09-11 | A |
| RANIERI RICHARD J | Officer | 19,233 | 2008-02-12 | S |
| MITCHELL W THOMAS | Director | 16,000 | 2015-06-23 | M |
| SHERWIN STEPHEN A | Director | 14,860 | 2026-09-02 | G |
| Boyer David W. | Officer | 11,484 | 2026-09-11 | A |
| MORROW GEORGE J | Director | 10,386 | 2026-05-21 | M |
| Mercier Johanna | Officer | 6,853 | 2026-05-21 | M |
| Keswani Sanjay Chandru | Officer | 5,393 | 2026-09-11 | A |
| POON CHRISTINE A | Director | 4,753 | 2026-05-21 | M |
| Sharp Shalini | Director | 4,088 | 2026-05-21 | M |
| Norwalk Leslie V | Director | 2,430 | 2026-07-29 | M |
| Ratz Andrew | Officer | 1,018 | 2026-03-15 | — |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-28 | ROBERTS EIRY | — | — | — | 51,331 |
| 2026-09-14 | ABERNETHY MATT | Open-market sale | 2,311 | $157.20 | 42,808 |
| 2026-09-14 | Boyer David W. | Open-market sale | 826 | $157.45 | 8,722 |
| 2026-09-11 | ABERNETHY MATT | Tax withholding | 2,709 | $156.22 | 45,119 |
| 2026-09-11 | ABERNETHY MATT | Grant / award | 5,020 | $0.00 | 47,828 |
| 2026-09-11 | BENEVICH ERIC | Tax withholding | 3,386 | $156.22 | 67,297 |
| 2026-09-11 | BENEVICH ERIC | Grant / award | 6,275 | $0.00 | 70,683 |
| 2026-09-11 | Boyer David W. | Tax withholding | 1,936 | $156.22 | 9,548 |
| 2026-09-11 | Boyer David W. | Grant / award | 3,587 | $0.00 | 11,484 |
| 2026-09-11 | Cooke Julie | Tax withholding | 1,936 | $156.22 | 24,025 |
| 2026-09-11 | Cooke Julie | Grant / award | 3,587 | $0.00 | 25,961 |
| 2026-09-11 | Delaet Ingrid | Tax withholding | 2,419 | $156.22 | 18,289 |
| 2026-09-11 | Delaet Ingrid | Grant / award | 4,483 | $0.00 | 20,708 |
| 2026-09-11 | Gano Kyle | Tax withholding | 994 | $156.22 | 154,728 |
| 2026-09-11 | Gano Kyle | Grant / award | 1,842 | $0.00 | 155,722 |
| 2026-09-11 | Gano Kyle | Tax withholding | 3,386 | $156.22 | 153,880 |
| 2026-09-11 | Gano Kyle | Grant / award | 6,275 | $0.00 | 157,266 |
| 2026-09-11 | GORMAN KEVIN CHARLES | Tax withholding | 7,839 | $156.22 | 517,797 |
| 2026-09-11 | GORMAN KEVIN CHARLES | Grant / award | 14,343 | $0.00 | 525,636 |
| 2026-09-11 | Keswani Sanjay Chandru | Tax withholding | 2,112 | $156.22 | 3,281 |
| 2026-09-11 | Keswani Sanjay Chandru | Grant / award | 3,914 | $0.00 | 5,393 |
| 2026-09-11 | Lippoldt Darin | Tax withholding | 2,419 | $156.22 | 56,793 |
| 2026-09-11 | Lippoldt Darin | Grant / award | 4,483 | $0.00 | 59,212 |
| 2026-09-11 | Onyia Jude | Tax withholding | 1,936 | $156.22 | 22,647 |
| 2026-09-11 | Onyia Jude | Grant / award | 3,587 | $0.00 | 24,583 |
| 2026-09-09 | BENEVICH ERIC | Option exercise (derivative) | 3,194 | $0.00 | 0 |
| 2026-09-09 | BENEVICH ERIC | Open-market sale | 2,154 | $154.61 | 64,408 |
| 2026-09-09 | BENEVICH ERIC | Option exercise | 3,194 | $43.24 | 66,562 |
| 2026-09-02 | SHERWIN STEPHEN A | Gift | 1,000 | $0.00 | 14,860 |
| 2026-08-04 | Onyia Jude | Gift | 2,409 | $0.00 | 20,996 |
| 2026-07-29 | Norwalk Leslie V | Option exercise (derivative) | 842 | $0.00 | 2,140 |
| 2026-07-29 | Norwalk Leslie V | Option exercise | 842 | $139.43 | 2,430 |
| 2026-07-28 | Norwalk Leslie V | Open-market sale | 1,250 | $182.01 | 1,588 |
| 2026-07-10 | Delaet Ingrid | Option exercise (derivative) | 4,367 | $0.00 | 0 |
| 2026-07-10 | Delaet Ingrid | Open-market sale | 4,367 | $181.02 | 16,225 |
| 2026-07-10 | Delaet Ingrid | Option exercise | 4,367 | $106.02 | 20,592 |
| 2026-07-09 | Delaet Ingrid | Option exercise (derivative) | 8,433 | $0.00 | 7,478 |
| 2026-07-09 | Delaet Ingrid | Open-market sale | 8,433 | $178.72 | 16,225 |
| 2026-07-09 | Delaet Ingrid | Option exercise | 8,433 | $103.52 | 24,658 |
| 2026-07-09 | Lippoldt Darin | Option exercise (derivative) | 10,000 | $0.00 | 4,965 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.